Thomas Marron, MD, PhD

img_Thomas Marron
PROFESSOR | Medicine, Hematology and Medical Oncology
PROFESSOR | Immunology & Immunotherapy
Are you a patient?
Specialties
Cancer (Oncology)

PhD, Mount Sinai School of Medicine of New York University

MD, Icahn School of Medicine at Mount Sinai

Residency, Internal Medicine, Mount Sinai Hospital and Medical Center

Fellowship, Medical Oncology, Mount Sinai Hospital and Medical Center

Publications

Selected Publications

Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. Pei Chang Lee, Alessio Cortellini, Bernardo Stefanini, Changhoon Yoo, Hong Jae Chon, Jaekyung Cheon, Masatoshi Kudo, Naoshi Nishida, Bernhard Scheiner, Matthias Pinter, Pasquale Lombardi, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Leonardo Brunetti, Aria Torkpour, Elena Valenzi, Fionnuala Crowley, Thomas U. Marron, Wei Fan Hsu, Ciro Celsa, Giuseppe Cabibbo, Calogero Cammà, Peter Robert Galle, Caterina Vivaldi, Gianluca Masi, Rohini Sharma, Ryan Po Ting Lin, Chun Yen Lin, Brooke Wietharn, Anwaar Saeed, Francesco Tovoli, Fabio Piscaglia, Andrea Dalbeni, Alessandra Auriemma, David Sacerdoti, Alessandro Parisi, Giulia Francesca Manfredi, Andrea Dondo, Lorenza Rimassa, Mario Pirisi, Martin Schönlein, Johann von Felden, Amit G. Singal, Neehar Dilip Parkih, Haripriya Andanamala, Susanna Ulahannan, Natascha Roehlen, Robert Thimme, Yi Hsiang Huang, David James Pinato. European Journal of Cancer

Author Correction: Innovative approaches for lung cancer screening and interception (Nature Reviews Clinical Oncology, (2026), 10.1038/s41571-026-01131-4). Jianjun Zhang, Matthew D. Park, Tej Pandya, Elaine Shum, Jia Wu, Simon Heeke, Ramin Salehi-Rad, Thomas U. Marron, Zhubo Wei, Hui Li, Torsten G. Blum, John V. Heymach, Steven M. Dubinett, Pan Chyr Yang, Charles Swanton, Miriam Merad. Nature Reviews Clinical Oncology

Innovative approaches for lung cancer screening and interception. Jianjun Zhang, Matthew D. Park, Tej Pandya, Elaine Shum, Jia Wu, Simon Heeke, Ramin Salehi-Rad, Thomas U. Marron, Zhubo Wei, Hui Li, Torsten G. Blum, John V. Heymach, Steven M. Dubinett, Pan Chyr Yang, Charles Swanton, Miriam Merad. Nature Reviews Clinical Oncology

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Marron during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Astellas Pharma Inc.
  • Storm
  • AN2 Therapeutics, Inc.
  • Merck & Co., Inc.
  • Evolveimmune
  • Caris Life Sciences
  • abdera
  • EMD Serono, Inc
  • AbbVie Biotherapeutics, Inc.
  • NTx Natures Toolbox

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.